.jpg)
FRF - Grand Est
Regional Innovation Performance (2019) Strong -
Total population (2019) 5525291
Population per km² (2017) 97
Proportion population older 65 year % 20,34%
Background
Grand Est (Alsace - Champagne-Ardenne - Lorraine) is a region in eastern France. The regions' S3 priorities in Health and Well-being include: e-health (prevention, autodiagnostic, tele-consultation and remote monitoring); ICT related aspects of e-health; New drugs (biotech, biomarkers, nanomaterial, genomics, chemistry and biology); Robotics & medical & surgical care (non-invasive mini surgery, micro-robots for the exploration of the body, tele-robotics and re-education, social robots for diagnosis and cognitive & emotional stimulation, robotics software); Tools for assisting diagnosis based on medical imagery (and ultra-sound); Medical implants (passive such as prothesis and active such as pacemakers); Prevention through nutrition.
The region would like to collaborate with: USA, Germany, Belgium, UK
Membership status
Member ICPerMed? no
Mountain ? Non-mountain
Member Euregha? no
Adriatic-Ionian MacroRegion? no
InnoStars Region? no
Northern Sparsely Populated Area (NSPA)? no
PM region according EC? yes
Baltic Sea MacroRegion? no
S3MedTech region? yes
Danube MacroRegion? no
S3ClusSport member? no
Alpine MacroRegion? no
S3P4PM region? no
Regions4PM region? no
Central Europe? no
MedTech4Europe? no
Council of European BioRegions (CEBR)? no
1M+Genome initiative? country level observer
European Regions Research & Innovation Network (ERRIN)? yes
Vanguard Initiative? no
ERAPerMed? no
Policy documents
Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Education, training and skill development; Prediction and prevention; Value based healthcare
- National Reimbursement of e- and mobile health applications
Health data populations study
Regional Education and training, linked to personalised medicine https://www.grandest.fr/objectif-sante/
Public-private partnerships https://www.ihu-strasbourg.eu/
NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives: C.20 - Chemicals and chemical products; C.21 - Basic pharmaceutical products and pharmaceutical preparations; J.63 - Information service activities; Q.86 - Human health activities; M.72 - Scientific research and development; P - Education
Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS07 - Health; NABS133 - R&D related to Medical Sciences - financed from other sources than GUF
Policy objective Personalised Medicine/Personalised Health related related to Research and Innovation objectives: D - Digital transformation; E.38 - Advanced materials; E.39 - Industrial biotechnology; G.46 - Ageing societies; G.49 - Public health & well-being; H - Service innovation; I.57 - Social innovation with regard to education, skills & training
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Major initiatives
Collaborations with Germany, switzerland
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
EIT Health/InnoStars/Regional Innovation Scheme (RIS)
Partnership between BioValley France and MEDTEQ Québec
Self evaluation
General perception of the implementation level of PM in the region - High
Rate of the need for developing and implementing PM in the region - Medium
Rate of the need for increasing support/funding for PM activities in the region - Very High
Rate of the need for increasing the capacity of PM skills in the region - Medium
Rate of the genomics literacy of the citizens in the region - High
Rate of the need for increasing interregional collaboration in PM - High
Image attribution
By Niko67000 - Own work, CC BY-SA 4.0,